{"title":"人乳头瘤病毒(HPV)及其毒性的认识","authors":"Aldar Arjanova","doi":"10.35248/2157-7560.20.11.E431","DOIUrl":null,"url":null,"abstract":"The population-level burden of HPV-positive OPSCC is currently unidentified and may have important implications to cancer prevention, potentially through HPV vaccination. Therefore, combined molecular epidemiologic methods that use both sensitive and specific laboratory assays with cancer surveillance methods to investigate the changes in the population-level epidemiology of OPSCC in the United States are caused by HPV infection to estimate the historical, current, and future population-level burden of HPV-positive OPSCCs.","PeriodicalId":17656,"journal":{"name":"Journal of Vaccines and Vaccination","volume":"84 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Awareness of Human papilloma Virus (HPV) and its Toxicity\",\"authors\":\"Aldar Arjanova\",\"doi\":\"10.35248/2157-7560.20.11.E431\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The population-level burden of HPV-positive OPSCC is currently unidentified and may have important implications to cancer prevention, potentially through HPV vaccination. Therefore, combined molecular epidemiologic methods that use both sensitive and specific laboratory assays with cancer surveillance methods to investigate the changes in the population-level epidemiology of OPSCC in the United States are caused by HPV infection to estimate the historical, current, and future population-level burden of HPV-positive OPSCCs.\",\"PeriodicalId\":17656,\"journal\":{\"name\":\"Journal of Vaccines and Vaccination\",\"volume\":\"84 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vaccines and Vaccination\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2157-7560.20.11.E431\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vaccines and Vaccination","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2157-7560.20.11.E431","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Awareness of Human papilloma Virus (HPV) and its Toxicity
The population-level burden of HPV-positive OPSCC is currently unidentified and may have important implications to cancer prevention, potentially through HPV vaccination. Therefore, combined molecular epidemiologic methods that use both sensitive and specific laboratory assays with cancer surveillance methods to investigate the changes in the population-level epidemiology of OPSCC in the United States are caused by HPV infection to estimate the historical, current, and future population-level burden of HPV-positive OPSCCs.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
